2 Fidelity ETFs To Buy Before 2026

Fidelity Blue Chip Growth ETF (FBCG) and Fidelity High Dividend ETF (FDVV) are highlighted as buy candidates ahead of 2026: FBCG is an actively managed, tech-heavy large-cap growth fund with $5.2B AUM, a 0.60% expense ratio, ~200 holdings concentrated in mega-cap tech (46% tech; top-10 = 63% including Nvidia, Microsoft, Amazon, Apple, Alphabet, Meta), 3-year return 32.85%, 5-year 15.07%, and YTD gain ~18.52% (price $55.16). FDVV tracks the Fidelity High Dividend Index with $7.67B net assets, 117 stocks, 0.15% expense ratio, 2.78% yield, sector mix skewed to tech/financials/consumer defensive (26%/19%/12%), top-10 = 34%, 3-year annualized 21.84% and 5-year 17.4%, and is positioned as a lower-risk, income-focused option that excludes high payout-ratio yield traps.

Analysis

Market structure: Concentration in mega-cap tech (FBCG top-10 = 63%) means incremental ETF flows disproportionately bid NVDA/MSFT/AMZN/AAPL/GOOGL/META, amplifying momentum and idiosyncratic risk. FDVV’s blend (26% tech, 19% financials) shows “high dividend” branding masks substantial tech exposure, so rotation away from growth would shift flows into true defensive staples (KO, PM) and financials (JPM, V) rather than pure value. The demand skew tightens liquidity in large-cap options and increases gamma/vega sensitivity around earnings; a 25–50bp move in 10yr yields would likely reprice tech multiples and push flows into dividend ETFs. Cross-asset: rising rates compress growth multiples (bond sell-offs), USD strength pressures multi-national revenues, and semiconductor-driven commodity demand (copper, palladium) remains a tail-upside for miners if AI capex sustains.

Risk assessment: Key tail risks are semiconductor export controls (material to NVDA), a Fed tightening surprise, or a sudden dividend cut in mid-cap holdings inside FDVV; probability low but impact high (>-30% on concentrated names). Near-term (days–weeks) risk centers on earnings/guide for NVDA/MSFT and Fed/CPI prints; medium-term (3–6 months) hinge on 10yr trajectory and AI capex realization; long-term (12–36 months) depends on structural AI TAM and dividend sustainability. Hidden dependency: overlapping ETF ownership creates correlated liquidation risk — a 10% drawdown in Magnificent Seven could propagate to otherwise defensive funds via redemption mechanics. Catalysts to watch: NVDA earnings, Fed meetings, CPI prints, and quarterly dividend announcements (JPM/PM).

Key Decisions for Investors

• Establish a 2.5% core long position in FDVV for a 6–12 month hold to harvest ~2.5% yield and lower realized volatility; trim/stop-loss if NAV yield falls below 2.2% or top-10 concentration rises above 40%.
• Allocate 1.5% long NVDA and 1.5% long MSFT (total 3%) funded by reducing passive small-cap exposure; add only in 25% tranches on 5% pullbacks and reassess after next earnings—take profits at +30% per leg.
• Place a paired tactical position: long FDVV 2.5% vs short FBCG 2% for 3–6 months to hedge a rates-driven growth-to-income rotation; unwind if 10yr Treasury yield drops >30bp from current level or spread performance reverses >5%.
• Buy 3–6 month put spreads on FBCG or QQQ sized at 0.5–1% of portfolio (e.g., buy 5%–7% OTM puts and sell 2%–3% OTMputs) to cap downside risk in a crowded tech market, especially around NVDA/MSFT earnings.
• Initiate a 12–18 month LEAP call position on NVDA (size 0.5–1%) financed by selling 1–3 month OTM calls on liquid S&P/QQQ exposure; target asymmetric upside to capture AI secular growth while funding theta.